Aqueous extract of Artemisia iwayomogi Kitamura attenuates cholestatic liver fibrosis in a rat model of bile duct ligation

Food and Chemical Toxicology

Volumn 50, Issue 10, 2012, Pages 3505-3513

  Han, Jong Min ^a   Kim, Hyeong Geug ^a   Choi, Min Kyung ^a   Lee, Jin Suk ^a   Park, Hye Jung ^a   Wang, Jing Hua ^b   Lee, Jong Suk ^c   Son, Seung Wan ^d   Hwang, Seock Yeon ^a   Son, Chang Gue ^a  

^a Daejeon University   (South Korea)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c Gyeonggi Institute of Science and Technology Promotion   (South Korea)

^d Korea University   (South Korea)

Author keywords

Artemisia iwayomogi Kitamura; Bile duct ligation; Cholestasis; Liver fibrosis; Scopoletin

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; ARTEMISIA IWAYOMOGI EXTRACT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CATALASE; COLLAGEN TYPE 1; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYPROLINE; MALONALDEHYDE; PLANT EXTRACT; PLATELET DERIVED GROWTH FACTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; SCLEROPROTEIN; SCOPARONE; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFIBROTIC ACTIVITY; ANTIOXIDANT ACTIVITY; AQUEOUS SOLUTION; ARTEMISIA; ARTEMISIA IWAYOMOGI; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT LIGATION; BILIRUBIN BLOOD LEVEL; BLOOD CELL COUNT; BODY WEIGHT; CHOLESTASIS; CHOLESTATIC LIVER FIBROSIS; CONTROLLED STUDY; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; GENE EXPRESSION; HEMATOLOGICAL PARAMETERS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; LIVER FIBROSIS; LIVER INJURY; LIVER PROTECTION; LIVER WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ACTINS; ANIMALS; ANTIOXIDANTS; ARTEMISIA; BILE DUCTS; CHOLESTASIS; COLLAGEN TYPE I; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION; HYDROXYPROLINE; LIGATION; LIVER CIRRHOSIS; MALE; MALONDIALDEHYDE; MOLECULAR STRUCTURE; NADH, NADPH OXIDOREDUCTASES; PLANT EXTRACTS; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; SCOPOLETIN; SPECIFIC PATHOGEN-FREE ORGANISMS; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

ARTEMISIA IWAYOMOGI; RATTUS;

EID: 84865511217     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.07.018     Document Type: Article

References (56)

1. Abraham S., Hermesz E., Szabo A., Ferencz A., Jancso Z., Duda E., Abraham M., Lazar G., Lazar G. Effects of Kupffer cell blockade on the hepatic expression of metallothionein and heme oxygenase genes in endotoxemic rats with obstructive jaundice. Life Sci. 2012, 90:140-146.
2. Aller M.A., Arias J.L., Garcia-Dominguez J., Arias J.I., Duran M., Arias J. Experimental obstructive cholestasis: the wound-like inflammatory liver response. Fibrogenesis Tissue Repair 2008, 1:6.
3. Alptekin N., Mehmetcik G., Uysal M., Aykac-toker G. Evidence for oxidative stress in the hepatic mitochondria of bile duct ligated rats. Pharmacol. Res. 1997, 36:243-247.
4. Beers R.F., Sizer I.W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 1952, 195:133-140.
5. Casini A., Ceni E., Salzano R., Biondi P., Parola M., Galli A., Foschi M., Caligiuri A., Pinzani M., Surrenti C. Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. Hepatology 1997, 25:361-367.
6. Chen W.Y., Chen C.J., Liao J.W., Mao F.C. Chromium attenuates hepatic damage in a rat model of chronic cholestasis. Life Sci. 2009, 84:606-614.
7. Choi W.S., Kim C.J., Park B.S., Lee S.E., Takeoka G.R., Kim D.G., Lanpiao X., Kim J.H. Inhibitory effect on proliferation of vascular smooth muscle cells and protective effect on CCl(4)-induced hepatic damage of HEAI extract. J. Ethnopharmacol. 2005, 100:176-179.
8. Cui W., Matsuno K., Iwata K., Ibi M., Matsumoto M., Zhang J., Zhu K., Katsuyama M., Torok N.J., Yabe-Nishimura C. NOX1/nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase promotes proliferation of stellate cells and aggravates liver fibrosis induced by bile duct ligation. Hepatology 2011, 54:949-958.
9. Dai L.J., Li H.Y., Guan L.X., Ritchie G., Zhou J.X. The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis. Stem Cell Res. 2009, 2:16-25.
10. De Bleser P.J., Xu G., Rombouts K., Rogiers V., Geerts A. Glutathione levels discriminate between oxidative stress and transforming growth factor-beta signaling in activated rat hepatic stellate cells. J. Biol. Chem. 1999, 274:33881-33887.
11. Desmet V., Roskams T., Van Eyken P. Ductular reaction in the liver. Pathol. Res. Pract. 1995, 191:513-524.
12. Dhiman R.K., Chawla Y.K. Herbal medicines for liver diseases. Dig. Dis. Sci. 2005, 50:1807-1812.
13. Dold S., Laschke M.W., Lavasani S., Menger M.D., Jeppsson B., Thorlacius H. Simvastatin protects against cholestasis-induced liver injury. Br. J. Pharmacol. 2009, 156:466-474.
14. Evans J.C., Ellman G.L. The ionization of cysteine. Biochim. Biophys. Acta 1959, 33:574-576.
15. Faubion W.A., Guicciardi M.E., Miyoshi H., Bronk S.F., Roberts P.J., Svingen P.A., Kaufmann S.H., Gores G.J. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J. Clin. Invest. 1999, 103:137-145.
16. Friedman S.L. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008, 134:1655-1669.
17. Fujita M., Shannon J.M., Morikawa O., Gauldie J., Hara N., Mason R.J. Overexpression of tumor necrosis factor-alpha diminishes pulmonary fibrosis induced by bleomycin or transforming growth factor-beta. Am. J. Respir Cell. Mol. Biol. 2003, 29:669-676.
18. Gressner A.M., Bachem M.G. Molecular mechanisms of liver fibrogenesis - a homage to the role of activated fat-storing cells. Digestion 1995, 56:335-346.
19. Gross J.B., Reichen J., Zeltner T.B., Zimmermann A. The evolution of changes in quantitative liver function tests in a rat model of biliary cirrhosis: correlation with morphometric measurement of hepatocyte mass. Hepatology 1987, 7:457-463.
20. Gunther U., Schuppan D., Bauer M., Matthes H., Stallmach A., Schmitt-Graff A., Riecken E.O., Herbst H. Fibrogenesis and fibrolysis in collagenous colitis. Patterns of procollagen types I and IV, matrix-metalloproteinase-1 and -13, and TIMP-1 gene expression. Am. J. Pathol. 1999, 155:493-503.
21. Haber B., Ferreira C.T., Aw M., Bezerra J., Sturm E., Thompson R., D'Agostino D., McKiernan P. Cholestasis: current issues and plan for the future. J. Pediatr. Gastroenterol. Nutr. 2008, 47:220-224.
22. Henderson N.C., Forbes S.J. Hepatic fibrogenesis: from within and outwith. Toxicology 2008, 254:130-135.
23. Hines J.E., Johnson S.J., Burt A.D. In vivo responses of macrophages and perisinusoidal cells to cholestatic liver injury. Am. J. Pathol. 1993, 142:511-518.
24. Huang W., Zhang J., Moore D.D. A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR. J. Clin. Invest. 2004, 113:137-143.
25. Imamura M., Ogawa T., Sasaguri Y., Chayama K., Ueno H. Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats. Gastroenterology 2005, 128:138-146.
26. Jang G. Jung Gyeong Jeon Seo 1975, Publishers, Seoul, Hollym Corp.
27. Kim A.R., Zou Y.N., Park T.H., Shim K.H., Kim M.S., Kim N.D., Kim J.D., Bae S.J., Choi J.S., Chung H.Y. Active components from Artemisia iwayomogi displaying ONOO(-) scavenging activity. Phytother. Res. 2004, 18:1-7.
28. Knodell R.G., Ishak K.G., Black W.C., Chen T.S., Craig R., Kaplowitz N., Kiernan T.W., Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981, 1:431-435.
29. Kwak K.G., Wang J.H., Shin J.W., Lee D.S., Son C.G. A traditional formula, Chunggan extract, attenuates thioacetamide-induced hepatofibrosis via GSH system in rats. Hum. Exp. Toxicol. 2011, 30:1322-1332.
30. Lee H.I., Seo K.O., Yun K.W., Kim M.J., Lee M.K. Comparative study of the hepatoprotective efficacy of Artemisia iwayomogi and Artemisia capillaris n ethanol-administered mice. J. Food Sci. 2011, 76:T207-T211.
31. Lee T.Y., Chang H.H., Chen J.H., Hsueh M.L., Kuo J.J. Herb medicine Yin-Chen-Hao-Tang ameliorates hepatic fibrosis in bile duct ligation rats. J. Ethnopharmacol. 2007, 109:318-324.
32. Lee T.Y., Chang H.H., Wu M.Y., Lin H.C. Yin-Chen-Hao-Tang ameliorates obstruction-induced hepatic apoptosis in rats. J. Pharm. Pharmacol. 2007, 59:583-590.
33. Levitan I., Volkov S., Subbaiah P.V. Oxidized LDL: diversity, patterns of recognition, and pathophysiology. Antioxid. Redox Signal. 2010, 13:39-75.
34. Lin H.J., Chen J.Y., Lin C.F., Kao S.T., Cheng J.C., Chen H.L., Chen C.M. Hepatoprotective effects of Yi Guan Jian, an herbal medicine, in rats with dimethylnitrosamine-induced liver fibrosis. J. Ethnopharmacol. 2011, 134:953-960.
35. Liu T.Z., Lee K.T., Chern C.L., Cheng J.T., Stern A., Tsai L.Y. Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor kappaB. Ann. Clin. Lab. Sci. 2001, 31:383-390.
36. Ljubuncic P., Tanne Z., Bomzon A. Evidence of a systemic phenomenon for oxidative stress in cholestatic liver disease. Gut 2000, 47:710-716.
37. Mihara M., Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 1978, 86:271-278.
38. Paradis V., Dargere D., Bonvoust F., Vidaud M., Segarini P., Bedossa P. Effects and regulation of connective tissue growth factor on hepatic stellate cells. Lab. Invest. 2002, 82:767-774.
39. Park E.J., Nan J.X., Kim J.Y., Kang H.C., Choi J.H., Lee S.J., Lee B.H., Kim S.J., Lee J.H., Kim Y.C., Sohn D.H. The ethanol-soluble part of a hot-water extract from Artemisia iwayomogi inhibits liver fibrosis induced by carbon tetrachloride in rats. J. Pharm. Pharmacol. 2000, 52:875-881.
40. Paumgartner G., Pauletzki J., Sackmann M. Ursodeoxycholic acid treatment of cholesterol gallstone disease. Scand. J. Gastroenterol. Suppl. 1994, 204:27-31.
41. Pinzani M., Rombouts K. Liver fibrosis: from the bench to clinical targets. Dig. Liver Dis. 2004, 36:231-242.
42. Recknagel R.O., Glende E.A., Dolak J.A., Waller R.L. Mechanisms of carbon tetrachloride toxicity. Pharmacol. Ther. 1989, 43:139-154.
43. Russell D.W. The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 2003, 72:137-174.
44. Saito J.M., Maher J.J. Bile duct ligation in rats induces biliary expression of cytokine-induced neutrophil chemoattractant. Gastroenterology 2000, 118:1157-1168.
45. Sanchez A., Alvarez A.M., Benito M., Fabregat I. Cycloheximide prevents apoptosis, reactive oxygen species production, and glutathione depletion induced by transforming growth factor beta in fetal rat hepatocytes in primary culture. Hepatology 1997, 26:935-943.
46. Sant'Anna L.B., Cargnoni A., Ressel L., Vanosi G., Parolini O. Amniotic membrane application reduces liver fibrosis in a bile duct ligation rat model. Cell. Transplant. 2011, 20:441-453.
47. Schmucker D.L., Ohta M., Kanai S., Sato Y., Kitani K. Hepatic injury induced by bile salts: correlation between biochemical and morphological events. Hepatology 1990, 12:1216-1221.
48. Seo K.S., Jeong H.J., Yun K.W. Antimicrobial activity and chemical components of two plants, Artemisia capillaris and Artemisia iwayomogi, used as Korean herbal Injin. J. Ecol. Field Biol. 2010, 33:141-147.
49. Seo K.S., Yun K.W. Antioxidant activities of extracts from Artemisia capillaris Thunb. and Artemisia iwayomogi Kitam. used as Injin. Korean J. Plant Res. 2008, 21:292-298.
50. Shin T.Y., Park J.S., Kim S.H. Artemisia iwayomogi inhibits immediate-type allergic reaction and inflammatory cytokine secretion. Immunopharmacol. Immunotoxicol. 2006, 28:421-430.
51. Sies H. Oxidative stress: oxidants and antioxidants. Exp. Physiol. 1997, 82:291-295.
52. Song M., Song Z., Barve S., Zhang J., Chen T., Liu M., Arteel G.E., Brewer G.J., McClain C.J. Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis. J. Pharmacol. Exp. Ther. 2008, 325:409-416.
53. Stedman C., Liddle C., Coulter S., Sonoda J., Alvarez J.G., Evans R.M., Downes M. Benefit of fanesoid X receptor inhibition in obstructive cholestasis. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:11323-11328.
54. Wang J.H., Choi M.K., Shin J.W., Hwang S.Y., Son C.G. Antifibrotic effects of Artemisia capillaris and Artemisia iwayomogi in a carbon tetrachloride-induced chronic hepatic fibrosis animal model. J. Ethnopharmacol. 2012, 140:179-185.
55. Webster C.R., Anwer M.S. Cyclic adenosine monophosphate-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes. Hepatology 1998, 27:1324-1331.
56. Zhang Z.J. Jing Gui Yao Lue Fang Lun Beijing 1978, People's Medical Publishing House.